www.diseases-diagnosis.com Homepage Diseases Symptoms Diseases Diagnosis Diseases Treatment Diseases Living Care Diseases Prevention Diseases Research
www
Search
March 26, 2016
Table of Contents

1 Introduction
Alfuzosin

Wikipedia

 

Alfuzosin ( INN , provided as the hydrochloride salt) is an ??1 receptor antagonist used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.

Alfuzosin is marketed in the United States by Sanofi Aventis under the brand name Uroxatral and elsewhere under the tradename Xatral . Alfuzosin was approved by the FDA for treatment of BPH in June 2003.




The most common side effects are dizziness (due to postural hypotension), upper respiratory tract infection, headache, and fatigue .




Alfuzosin should be used with caution in patients with severe renal insufficiency, and should not be prescribed to patients with a known history of QT prolongation who are taking medications known to prolong the QT interval.




  • Uroxatral (manufacturer's website)

  • Alfuzosin (patient information)



This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alfuzosin".


Last Modified:   2010-11-29


Search
All informatin on the site is © www.diseases-diagnosis.com 2002-2011. Last revised: January 2, 2011
Are you interested in our site or/and want to use our information? please read how to contact us and our copyrights.
To let us provide you with high quality information, you can help us by making a more or less donation: